Department of Pharmacy, Qilu Hospital of Shandong University, Jinan, China.
Department of Emergency Medicine and Chest Pain Center, Qilu Hospital of Shandong University, Jinan, China.
FASEB J. 2019 May;33(5):6584-6595. doi: 10.1096/fj.201802020R. Epub 2019 Feb 22.
LPS has been shown to elicit neuroinflammation associated with the up-regulation of the eicosanoid pathway in animal models; however, the regulatory mechanisms of TLR4 in brain neuroinflammatory conditions remain elusive. β-Arrestins are key regulators of the GPCR signaling pathway and are involved in the leukotriene B4-induced leukocyte migration to initiate inflammatory response. However, the roles of β-arrestins in eicosanoid regulation and related diseases are not clear. To address this issue, we conducted a study to investigate the effect of TLR4 on the eicosanoid pathway in ischemic stroke brain and to explore the underlying molecular regulation mechanism. Cerebral ischemia was produced by occlusion of the middle cerebral artery, followed by reperfusion for 24 h. We demonstrated that knockout of TLR4 improves ischemic stroke brain associated with eicosanoid down-regulation. Interestingly, genetic disruption of β-arrestin-2 failed to decrease neuroinflammation in the damaged brain of TLR4 mice, which indicates the requirement of β-arrestin-2 for TLR4 knockdown protection. Further study showed that the negative regulation of phosphorylated (phospho-)ERK1/2 and phospho-cytosolic phospholipase A α (cPLAα) by TLR4 deficiency was eliminated by genetic disruption of β-arrestin-2. In addition, β-arrestin-2 deficiency reversed the reduction of colocalization of phospho-ERK1/2 with phospho-cPLAα in TLR4 mice following ischemic stroke. Mechanistic studies indicated that β-arrestin-2 specifically colocalized and associated with ERK1/2 to prevent ERK1/2-dependent cPLAα activation following ischemic injury, and β-arrestin-2 deficiency blocked the negative regulation of phospho-ERK1/2, revived the association of phospho-ERK1/2 with phospho-cPLAα, and subsequently increased the prostaglandin E2 and thromboxane A2 production remarkably. Our findings may provide novel insights that β-arrestin-2 is responsible for ischemic brain improvement in TLR4 mice negative regulation of eicosanoid production.-Xiang, Y., Wei, X., Du, P., Zhao, H., Liu, A., Chen, Y. β-Arrestin-2-ERK1/2 cPLAα axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain.
脂多糖(LPS)已被证明可引发与动物模型中类二十烷酸途径上调相关的神经炎症;然而,TLR4 在脑神经炎症中的调节机制仍不清楚。β- arrestin 是 GPCR 信号通路的关键调节剂,参与白三烯 B4 诱导的白细胞迁移以启动炎症反应。然而,β-arrestin 在类二十烷酸调节和相关疾病中的作用尚不清楚。为了解决这个问题,我们进行了一项研究,以调查 TLR4 在缺血性中风脑内类二十烷酸途径中的作用,并探讨潜在的分子调节机制。通过大脑中动脉闭塞再灌注 24 小时来产生脑缺血。我们证明 TLR4 敲除可改善与类二十烷酸下调相关的缺血性中风脑。有趣的是,β-arrestin-2 的基因缺失未能减少 TLR4 敲除小鼠受损大脑中的神经炎症,这表明β-arrestin-2 是 TLR4 敲低保护所必需的。进一步的研究表明,TLR4 缺乏引起的磷酸化(phospho-)ERK1/2 和磷酸细胞质磷脂酶 Aα(cPLAα)的负调节被β-arrestin-2 的基因缺失所消除。此外,β-arrestin-2 缺乏逆转了缺血性中风后 TLR4 小鼠中磷酸化 ERK1/2 与磷酸化 cPLAα 的共定位减少。机制研究表明,β-arrestin-2 特异性与 ERK1/2 共定位并与之相关,以防止缺血损伤后 ERK1/2 依赖性 cPLAα 激活,β-arrestin-2 缺乏阻断了 phospho-ERK1/2 的负调节,恢复了 phospho-ERK1/2 与 phospho-cPLAα 的关联,并随后显著增加前列腺素 E2 和血栓素 A2 的产生。我们的研究结果可能提供新的见解,即β-arrestin-2 负责 TLR4 敲除小鼠缺血性脑改善中对类二十烷酸产生的负调节。